NHS Trials Breakthrough Treatment Claimed To Stop 100% Of Symptomatic Infections

by : Emma Rosemurgey on :
NHS Trials Breakthrough Treatment Claimed To Stop 100% Of Symtopmatic InfectionsPA Images

The creators of a drug currently being trialled by the NHS say it is 100% effective in protecting against symptomatic cases of COVID-19.

Regeneron Pharmaceuticals claims its antibody drug, REGEN-COV, reduces overall coronavirus cases by 50%, Sky News reports.


The results are based on the confirmatory stage of the trials, which will not be complete until the second quarter of 2021, however it is hoped the drug could help ‘break the chain’ of infections.

REGEN-COV was trialled on 400 people, all of whom had a family member with COVID-19 living in the same house.

Sadiq Khan Declares COVID Emergency In LondonPA Images

Regeneron boss George Yancopoulos said that even with the vaccine rollout, hundreds of thousands of people are still ‘actively spreading the virus to their close contacts’.


Government Poised To Finally Increase NHS Workers Pay Rise

published at10 months ago

‘The REGEN-COV antibody cocktail may be able to help break this chain by providing immediate passive immunity to those at high risk of infection, in contrast to active vaccines which take weeks to provide protection,’ he continued.

The drug works by combining two antibodies, which together create a protein on the surface of the virus, blocking infections of SARS-CoV-2, which is the virus that causes COVID-19.

Vaccine USPA Images

REGEN-COV will be given to anyone considered to need ‘immediate protection’, particularly those who live with or who have come into contact with someone who has tested positive.


However, it will also be administered to people who ‘respond poorly to vaccination’ as it already includes antibodies, rather than relying on the body to produce its own, as with traditional vaccines.

If you have a story you want to tell, send it to UNILAD via [email protected]

Most Read StoriesMost Read


At Least 21 People Now Dead In Texas Elementary School Shooting

Emma Rosemurgey

Emma Rosemurgey is an NCTJ trained Journalist who started her career by producing The Royal Rosemurgey newspaper in 2004, which kept her family up to date with the goings on of her sleepy north east village. She graduated from the University of Central Lancashire in Preston and started her career in regional newspapers before joining Tyla (formerly Pretty 52) in 2017, and progressing onto UNILAD in 2019.

Topics: Health, Coronavirus, COVID-19, NHS, Now, UK


Sky News
  1. Sky News

    COVID-19: Breakthrough treatment claims to stop 100% of symptomatic infections